Brief: Monopar Expands Leadership Team With Appointment Of Seasoned Biopharma Executive Susan Rodriguez As Chief Commercial And Strategy Officer
02/03/2026 13:16
March 2 (Reuters) - Monopar Therapeutics Inc MNPR.O: MONOPAR EXPANDS LEADERSHIP TEAM WITH APPOINTMENT OF SEASONED BIOPHARMA EXECUTIVE SUSAN RODRIGUEZ AS CHIEF COMMERCIAL AND STRATEGY OFFICER Source text: ID:nGNX3LZGyR Further company coverage: MNPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla